Dual infection with HIV-1 and HIV-2: double trouble or destructive interference?

By de Silva Thushan I   van Tienen Carla   Rowland-Jones Sarah L   Cotten Matthew  

HIV Therapy, Vol. 4, Iss. 3, 2010-05 ,pp. : 305-323

Future Medicine

Access to resources Recommend Favorite

HIV, Metabolic Syndrome X, Inflammation, Oxidative Stress, and Coronary Heart Disease Risk : Role of Protease Inhibitor Exposure

By Hurwitz Barry E.   Klimas Nancy G.   Llabre Maria M.   Maher Kevin J.   Skyler Jay S.   Bilsker Martin S.   McPherson-Baker Shvawn   Lawrence Peter J.   LaPerriere Arthur R.   Greeson Jeffrey M.   Klaus Johanna R.   Lawrence Rasha   Schneiderman Neil  

Cardiovascular Toxicology, Vol. 4, Iss. 3, 2004-08 ,pp. : 303-316

Humana Press, Inc

Access to resources Recommend Favorite

Oxidative Stress in HIV Patients Receiving Antiretroviral Therapy

By  

Current HIV Research, Vol. 12, Iss. 1, 2014-01 ,pp. : 13-21

Bentham Science Publishers

Access to resources Recommend Favorite

When should antiretroviral therapy be started for HIV-infected infants in resource-limited settings?

By Prendergast Andrew   Cotton Mark   Gibb Diana M  

Future HIV Therapy, Vol. 2, Iss. 3, 2008-05 ,pp. : 201-208

Future Medicine

Access to resources Recommend Favorite

Virtual Physiological Human research initiative: the future for rational HIV treatment design?

By Stoica Ileana   Sadiq S Kashif   Gale Catherine V   Coveney Peter V  

Future HIV Therapy, Vol. 2, Iss. 5, 2008-09 ,pp. : 419-425

Future Medicine

Access to resources Recommend Favorite